Letters to the Editor
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart
C. Perricone1, P. Conigliaro2, C. Ciccacci3, E. Marcucci4, G. Cafaro5, E. Bartoloni6, R. Perricone7, G. Novelli8, P. Borgiani9, R. Gerli10
- Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
- UniCamillus, Saint Camillus International University of Health Sciences, Rome, and Department of Biomedicine and Prevention, Section of Genetics, School of Medicine, University of Rome Tor Vergata, Rome, Italy.
- Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
- Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
- Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
- Department of Biomedicine and Prevention, Section of Genetics, School of Medicine, University of Rome Tor Vergata, Rome, Italy.
- Department of Biomedicine and Prevention, Section of Genetics, School of Medicine, University of Rome Tor Vergata, Rome, Italy.
- Rheumatology Unit, Department of Medicine, University of Perugia, Italy. roberto.gerli@unipg.it
CER13519
2020 Vol.38, N°3
PI 0580
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 32452345 [PubMed]
Received: 04/05/2020
Accepted : 06/05/2020
In Press: 10/05/2020
Published: 27/05/2020
